SET DESIGNER MARY KATE GOLDING FOUND DEAD IN QUEENS HOME AS POLICE INVESTIGATE POSSIBLE MURDER-SUICIDE. (PHOTO).

Image
 Set designer Mary Kate Golding found dead in Queens home as police investigate possible murder-suicide Police are investigating the deaths of television set designer Mary Kate Golding and her husband after the 34-year-old was found fatally stabbed inside her Queens home. According to the New York Police Department, officers responded shortly after midnight on Tuesday, July 21, to a residence in Astoria, where they found Golding with a fatal stab wound to her back. She was pronounced dead at the scene. Several hours later, at about 6:39 a.m., officers responded to a separate 911 call reporting an unconscious person near Astoria Park South and Shore Boulevard. Police found an unresponsive man in the park, and he was pronounced dead at the scene. An NYPD source identified the man as Joseph Azzaretto, Golding's husband. The same source said investigators are treating the case as a possible murder-suicide. Authorities have not released additional details about the circumstances surroun...

KENYA HAILS FIRST ROLLOUT OF HIV PREVENTION DRUG LENACAPAVIR. (PHOTO).


 Kenya hails first rollout of HIV prevention drug Lenacapavir


Kenya began administering the first dose of a groundbreaking HIV prevention drug in a Nairobi slum on Thursday.


Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, though it is technically a chemical drug rather than a vaccine because it does not train the immune system.


"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale said during the rollout, AFP reported.


Kenya was among nine African countries selected last year to introduce lenacapavir, which has already been introduced in South Africa, Eswatini and Zambia since December.


There are roughly 1.3 million people living with HIV in Kenya, with the highest burden among those aged 15 to 24.


‘Renewed strength’


"Many of our young people still face the risk of infection... this innovation gives us renewed strength in our national fight against HIV," Duale, said adding that the drug will be free to those receiving it.


Last week, Kenya received its first batch of 21,000 doses through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS.


Lenacapavir offers greater privacy compared to regularly visits to health clinics for treatment, said Carol Njomo, a community health worker in Nairobi's Kawangware area, where the first doses were administered.


"This is an added protection," said Samson Mutua, 27, the first person to receive the injection.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.